Sidney Scudder
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 17
-
- Endometrial and Cervical Cancer Treatments 8
- Co-authors
- David R. GandaraRobert J. MorganAgustin A. GarcíaGini F. FlemingAmit M. OzaHeinz‐Josef LenzFrederick J. MeyersDongyun Yang
- Journals
- Journal of Clinical Oncology (10 papers)International Journal of Gynecological Cancer (8 papers)Gynecologic Oncology (7 papers)Cancer Research (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesCanadaTaiwan
In The Last Decade
Sidney Scudder
48 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 93
- Reproductive Medicine 578
- Obstetrics and Gynecology 339
- Oncology 603
- Cancer Research 286
- Internal Medicine 54
Countries citing papers authored by Sidney Scudder
This map shows the geographic impact of Sidney Scudder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sidney Scudder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sidney Scudder more than expected).
Fields of papers citing papers by Sidney Scudder
This network shows the impact of papers produced by Sidney Scudder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sidney Scudder. The network helps show where Sidney Scudder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sidney Scudder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 8 | |
| 3 | 2018 | 35 | |
| 4 | 2014 | 15 | |
| 5 | A PHASE 1B STUDY OF TREBANANIB (AMG 386) IN COMBINATION WITH PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) OR TOPOTECAN (T) IN WOMEN WITH RECURRENT OVARIAN CANCER | 2012 | 1 |
| 6 | 2009 | 39 | |
| 7 | 2008 | 137 | |
| 8 | 2007 | 8 | |
| 9 | 2007 | 6 | |
| 10 | 2006 | 18 | |
| 11 | 2006 | 12 | |
| 12 | 2004 | 37 | |
| 13 | 2004 | 48 | |
| 14 | 2004 | 11 | |
| 15 | 2003 | 114 | |
| 16 | 1999 | 12 | |
| 17 | 1998 | 22 | |
| 18 | 1991 | 19 | |
| 19 | 1991 | 40 | |
| 20 | 1988 | 23 |
About Sidney Scudder
Sidney Scudder is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Internal Medicine, Cancer Research and Oncology, having authored 49 papers that have together received 1.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (17 papers), Cancer Genomics and Diagnostics (9 papers), Endometrial and Cervical Cancer Treatments (8 papers), Lung Cancer Treatments and Mutations (8 papers), Colorectal and Anal Carcinomas (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer therapeutics and mechanisms (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Reproductive Medicine (578 citations), Obstetrics and Gynecology (339 citations), Oncology (603 citations), Cancer Research (286 citations) and Internal Medicine (54 citations). Sidney Scudder has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include David R. Gandara, Robert J. Morgan, Agustin A. García, Gini F. Fleming, Amit M. Oza, Heinz‐Josef Lenz, Frederick J. Meyers, Dongyun Yang, Lynda D. Roman and Hal W. Hirte. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology, Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.